Navigation Links
FDA cracks the whip on manufacturers of unapproved Cold Medicines

The Food and Drug Administration has issued a warning to the manufacturers of unauthorized medicines for cough and cold which include the drug carbinoxamine. // The companies have been given time from 30 to 90 days by which time they should completely stop selling these medicines.

The FDA announced that this drug is known to be unsafe for treating cough and cold in children yet is being administered to children, illegally.

The manufacturers could consider applying to the FDA for approval but it is mandatory to prove that the drug is safe for use on children. Those companies that choose to continue selling the drug despite the warning will be penalized, the FDA has warned.


Page: 1

Related medicine news :

1. Chemists prepare for face-off with manufacturers
2. Karla: healthy beer as claimed by German manufacturers
3. Imprisonment for fake “baby milk” manufacturers in Chia
4. Anti-smoking advertisements to be funded by Cigarette manufacturers
5. Medicines on the move
6. Advent of New, More Effective and Personalized Medicines
7. Be Wary Of Heavy Metal Poisoning From Ayurvedic Medicines
8. Metal In Medicines Can Fight Diseases Effectively
9. Medicines Used In Antiplatelet Therapy Can Reduce Heart Attacks And Strokes
10. Heart Patients More At Risk Get Fewer Medicines
11. Export Of Ayurvedic Medicines Affected Due To High Heavy Metal Content
Post Your Comments:

(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... will provide scholarships for people struggling with eating disorders as a result of ... the second annual event, held at Fox Run Golf Club in Eureka, will ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... that it has undertaken significant expansion of its current state of the art ... part of PharmaTech’s strategy to increase its manufacturing capacity as well as to ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a ... (TSC), as well as raising public awareness of the disorder while helping to ... third donation of $35,000 to bolster progress at the Tuberous Sclerosis Complex Center ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... treatment, is offering lower prices in an early celebration of the early holiday ... promotional price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Dr. Todd S. ... offer laser services to many of his patients. Dr. Afferica now uses the BIOLASE ... reduce the amount of time the doctor uses other traditional cutting tools, such as ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
(Date:11/24/2015)... 24, 2015  Natera, Inc. (Nasdaq: ... testing and the analysis of circulating cell-free ... at the 27 th  Annual Piper Jaffray ... p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of Natera, ... activities and financial outlook.  ...
(Date:11/24/2015)... COMMACK, New York , 24. November ... Hersteller des Avery Breathing Pacemaker Systems, ist ... Ph.D., als Clinical Consultant bekannt geben zu ... -->   --> ... Stockholm (Schweden). Von 1984-1986 ...
Breaking Medicine Technology: